In June 2014, the first clinical trial of a new type of bednet, Olyset® Duo produced by Sumitomo Chemical Company began in the Banfora region of Burkina Faso. This bednet contains two chemicals: a conventional pyrethroid insecticide to rapidly kill mosquitoes, and an insect sterilizing agent, to prevent any resistant mosquitoes that do survive the insecticide from laying eggs. The trial will involve nets being distributed throughout the population of over 60,000 people and the impact on malaria will be evaluated over a two year period.The clinical evaluation of Olyset Duo® is being led by members of the AvecNet Consortium Centre National de Recherche et de Formation sur le Paludisme CNRFP and the University of Durham, with researchers from LSTM evaluating the impact on resistance. Professor Hilary Ranson, AvecNet Consortium Leader and Head of LSTM’s Department of Vector Biology, said: “These nets have the potential to provide a solution to the problem of insecticide, but evaluation of their effectiveness under field settings is key. By evaluating new tools, such as Olyset Duo® and strengthening capacity for field trials AvecNet is aiding the translation of research and product development into new solutions for malaria control in Africa.”

via AvecNet sponsored trial of Oyset Duo Bednet is underway in Burkina Faso – Liverpool School of Tropical Medicine.